Alnylam Pharmaceuticals

Develops novel therapeutics-based RNAi and provides overviews of recent drug development programs.

HQ location

Cambridge, United States

Website

Launch date

2002

Employees

1001-5000 people

Market cap

Enterprise value

$40.8b

Share price

$326.09 ALNY

https://twitter.com/alnylam https://www.linkedin.com/company/alnylam-pharmaceuticals alnylampharma

Authorizing premium user...